Snapshots

Search

Search managers or tickers

RXRX Recursion Pharmaceuticals In

held by 1 manager in Q3 2023 Latest
Manager% of their portfolioHeldActivityValueShares
Stanley Druckenmiller Duquesne Family Office 0.25% 2.3 yr Reduce 34.6% $7M 906,767